Tightrope walking with Glanzmann’s disease

1. Poon MC, Di Minno G, d'Oiron R, Zotz R. New insights into the treatment of Glanzmann thrombasthenia. Transfus Med Rev 2016; 30(2): 92-9.10.1016/j.tmrv.2016.01.00126968829Open DOISearch in Google Scholar

2. Engelen ET, van Galen KP, Schutgens RE. Thalidomide for treatment of gastrointestinal bleedings due to angiodysplasia: a case report in acquired von Willebrand syndrome and review of the literature. Haemophilia 2015;21(4): 419-29.10.1111/hae.1270125929157Search in Google Scholar

3. Sami SS, Al-Araji SA, Ragunath K. Review article: gastrointestinal angiodysplasia - pathogenesis, diagnosis and management. Aliment Pharmacol Ther 2014; 39(1): 15-34.10.1111/apt.1252724138285Search in Google Scholar

4. Alikhan R, Keeling D. Von Willebrand disease, angiodysplasia and atorvastatin. Br J Haematol 2010;149(1): 159-60.10.1111/j.1365-2141.2009.08031.x19995387Search in Google Scholar

5. Leebeek FWG, Mauser-Bunschoten EP, Utrecht. Dutch guidelines for diagnosis and treatment of hemophilia and other rare bleeding disorders. ISBN 987-90-8253-195-0. 2009.Search in Google Scholar

1. Solh T, Botsford A, Solh M. Glanzmann's thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options. J Blood Med 2015; 6: 219-27.10.2147/JBM.S71319450124526185478Search in Google Scholar

2. Bauditz J. Effective treatment of gastrointestinal bleeding with thalidomide - chances and limitations. World J Gastroenterol 2016; 22(11): 3158-64.10.3748/wjg.v22.i11.3158478999027003992Open DOISearch in Google Scholar

3. Sohal M, Laffan M. Von Willebrand disease and angiodysplasia responding to atorvastatin. Br J Haematol 2008; 142(2): 308-9.10.1111/j.1365-2141.2008.07005.x18510690Search in Google Scholar

4. Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology, 9th edn. Philadelphia, PA: Elsevier Saunders; 2012.Search in Google Scholar